Manulife Reports Record 2025 Earnings, Boosts Dividend by 10.2%, and Announces New Share Buyback Program

summarizeSummary

Manulife Financial reported record 2025 core earnings and new business results, alongside a 10.2% dividend increase and a new share repurchase program for up to 2.5% of outstanding shares, signaling strong financial health and commitment to shareholder returns.

check_boxKey Events

• Record 2025 Core Earnings and New Business Results

  Manulife reported record core earnings of $7.5 billion for the full year 2025, up 3% on a constant exchange rate basis from 2024, and $2.0 billion in Q4 2025, up 5% from Q4 2024. Insurance new business results also reached record levels, with APE sales up 14%, new business CSM up 28%, and new business value up 18% from 2024.

• Significant 10.2% Quarterly Dividend Increase

  The Board of Directors announced a 10.2% increase in the quarterly common shareholders' dividend, raising it by 4.5 cents per share to $0.485 per share, payable on March 19, 2026. This substantial increase reflects strong financial performance and confidence in future profitability.

• New Share Repurchase Program Announced

  The company announced a new Normal Course Issuer Bid (NCIB) program, permitting the repurchase of up to approximately 2.5% of outstanding common shares. This program, expected to commence in late February 2026, represents a significant capital return initiative for shareholders.

• Strategic Growth and Capital Deployment

  Manulife highlighted strategic investments including the acquisition of Comvest Credit Partners, entry into India's life insurance market through a joint venture, and the acquisition of Schroders Indonesia, expanding its global footprint and diversified portfolio.

auto_awesomeAnalysis

This filing details Manulife Financial's robust financial performance for fiscal year 2025, including record core earnings and strong new business results. The company's decision to increase its quarterly common share dividend by a significant 10.2% and initiate a new Normal Course Issuer Bid (NCIB) program to repurchase up to 2.5% of outstanding common shares underscores strong management confidence in its financial health and future cash flow generation. These capital allocation strategies, representing a substantial return to shareholders, are highly positive signals, especially as the stock is trading near its 52-week high. This filing provides the detailed financial results and capital return specifics that complement the concurrent 40-F filing.